nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—epilepsy syndrome	0.257	0.706	CbGaD
Topotecan—ABCB1—epilepsy syndrome	0.107	0.294	CbGaD
Topotecan—ABCB1—Levetiracetam—epilepsy syndrome	0.0352	0.0907	CbGbCtD
Topotecan—ABCB1—Clobazam—epilepsy syndrome	0.0244	0.0628	CbGbCtD
Topotecan—ABCB1—Lamotrigine—epilepsy syndrome	0.0235	0.0605	CbGbCtD
Topotecan—ABCB1—Carbamazepine—epilepsy syndrome	0.0202	0.0521	CbGbCtD
Topotecan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0193	0.0497	CbGbCtD
Topotecan—ABCB1—Phenytoin—epilepsy syndrome	0.0181	0.0467	CbGbCtD
Topotecan—CYP3A4—Felbamate—epilepsy syndrome	0.0179	0.0462	CbGbCtD
Topotecan—CYP3A4—Trimethadione—epilepsy syndrome	0.0179	0.0462	CbGbCtD
Topotecan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0168	0.0434	CbGbCtD
Topotecan—ABCB1—Phenobarbital—epilepsy syndrome	0.0162	0.0416	CbGbCtD
Topotecan—ABCB1—Midazolam—epilepsy syndrome	0.0159	0.041	CbGbCtD
Topotecan—ABCB1—Diazepam—epilepsy syndrome	0.0153	0.0395	CbGbCtD
Topotecan—CYP3A4—Clonazepam—epilepsy syndrome	0.0152	0.0393	CbGbCtD
Topotecan—CYP3A4—Clobazam—epilepsy syndrome	0.0146	0.0376	CbGbCtD
Topotecan—CYP3A4—Rufinamide—epilepsy syndrome	0.0124	0.032	CbGbCtD
Topotecan—CYP3A4—Carbamazepine—epilepsy syndrome	0.0121	0.0312	CbGbCtD
Topotecan—CYP3A4—Primidone—epilepsy syndrome	0.0113	0.0291	CbGbCtD
Topotecan—CYP3A4—Phenytoin—epilepsy syndrome	0.0109	0.028	CbGbCtD
Topotecan—CYP3A4—Propofol—epilepsy syndrome	0.0101	0.0261	CbGbCtD
Topotecan—CYP3A4—Phenobarbital—epilepsy syndrome	0.00968	0.0249	CbGbCtD
Topotecan—CYP3A4—Acetazolamide—epilepsy syndrome	0.00968	0.0249	CbGbCtD
Topotecan—CYP3A4—Midazolam—epilepsy syndrome	0.00954	0.0246	CbGbCtD
Topotecan—CYP3A4—Diazepam—epilepsy syndrome	0.00917	0.0236	CbGbCtD
Topotecan—CYP3A4—Zonisamide—epilepsy syndrome	0.00895	0.0231	CbGbCtD
Topotecan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00723	0.0186	CbGbCtD
Topotecan—CYP3A4—Topiramate—epilepsy syndrome	0.00652	0.0168	CbGbCtD
Topotecan—TOP1MT—head—epilepsy syndrome	0.00126	0.0943	CbGeAlD
Topotecan—TOP1MT—nervous system—epilepsy syndrome	0.00119	0.0894	CbGeAlD
Topotecan—Irinotecan—ABCC2—epilepsy syndrome	0.00115	0.28	CrCbGaD
Topotecan—TOP1MT—central nervous system—epilepsy syndrome	0.00115	0.0861	CbGeAlD
Topotecan—TOP1MT—cerebellum—epilepsy syndrome	0.00112	0.0841	CbGeAlD
Topotecan—Irinotecan—BCHE—epilepsy syndrome	0.00108	0.263	CrCbGaD
Topotecan—TOP1—telencephalon—epilepsy syndrome	0.00106	0.0799	CbGeAlD
Topotecan—Irinotecan—ABCG2—epilepsy syndrome	0.00102	0.247	CrCbGaD
Topotecan—TOP1MT—brain—epilepsy syndrome	0.00091	0.0683	CbGeAlD
Topotecan—TOP1—medulla oblongata—epilepsy syndrome	0.000836	0.0628	CbGeAlD
Topotecan—TOP1—midbrain—epilepsy syndrome	0.000764	0.0574	CbGeAlD
Topotecan—TOP1—spinal cord—epilepsy syndrome	0.000745	0.056	CbGeAlD
Topotecan—TOP1—cerebellum—epilepsy syndrome	0.000591	0.0444	CbGeAlD
Topotecan—TOP1—brain—epilepsy syndrome	0.00048	0.0361	CbGeAlD
Topotecan—Irinotecan—ALB—epilepsy syndrome	0.000445	0.108	CrCbGaD
Topotecan—Irinotecan—ABCB1—epilepsy syndrome	0.000424	0.103	CrCbGaD
Topotecan—ABCG2—telencephalon—epilepsy syndrome	0.000377	0.0283	CbGeAlD
Topotecan—ABCG2—medulla oblongata—epilepsy syndrome	0.000297	0.0223	CbGeAlD
Topotecan—ABCG2—midbrain—epilepsy syndrome	0.000271	0.0204	CbGeAlD
Topotecan—ABCG2—spinal cord—epilepsy syndrome	0.000264	0.0199	CbGeAlD
Topotecan—ABCG2—cerebellum—epilepsy syndrome	0.00021	0.0157	CbGeAlD
Topotecan—ABCB1—forebrain—epilepsy syndrome	0.000202	0.0152	CbGeAlD
Topotecan—ABCB1—telencephalon—epilepsy syndrome	0.000186	0.014	CbGeAlD
Topotecan—ABCG2—brain—epilepsy syndrome	0.00017	0.0128	CbGeAlD
Topotecan—CYP3A4—nervous system—epilepsy syndrome	0.000155	0.0117	CbGeAlD
Topotecan—CYP3A4—central nervous system—epilepsy syndrome	0.000149	0.0112	CbGeAlD
Topotecan—ABCB1—medulla oblongata—epilepsy syndrome	0.000146	0.011	CbGeAlD
Topotecan—ABCB1—midbrain—epilepsy syndrome	0.000134	0.01	CbGeAlD
Topotecan—ABCB1—spinal cord—epilepsy syndrome	0.00013	0.00979	CbGeAlD
Topotecan—ABCB1—head—epilepsy syndrome	0.000116	0.0087	CbGeAlD
Topotecan—ABCB1—nervous system—epilepsy syndrome	0.00011	0.00825	CbGeAlD
Topotecan—ABCB1—central nervous system—epilepsy syndrome	0.000106	0.00794	CbGeAlD
Topotecan—ABCB1—cerebellum—epilepsy syndrome	0.000103	0.00776	CbGeAlD
Topotecan—Anaphylactic shock—Valproic Acid—epilepsy syndrome	8.82e-05	0.000465	CcSEcCtD
Topotecan—Urticaria—Lamotrigine—epilepsy syndrome	8.81e-05	0.000465	CcSEcCtD
Topotecan—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	8.81e-05	0.000465	CcSEcCtD
Topotecan—Malaise—Pregabalin—epilepsy syndrome	8.81e-05	0.000465	CcSEcCtD
Topotecan—Nausea—Propofol—epilepsy syndrome	8.8e-05	0.000464	CcSEcCtD
Topotecan—Vomiting—Fosphenytoin—epilepsy syndrome	8.79e-05	0.000464	CcSEcCtD
Topotecan—Diarrhoea—Felbamate—epilepsy syndrome	8.78e-05	0.000463	CcSEcCtD
Topotecan—Abdominal pain—Lamotrigine—epilepsy syndrome	8.77e-05	0.000463	CcSEcCtD
Topotecan—Body temperature increased—Lamotrigine—epilepsy syndrome	8.77e-05	0.000463	CcSEcCtD
Topotecan—Dizziness—Diazepam—epilepsy syndrome	8.77e-05	0.000463	CcSEcCtD
Topotecan—Infection—Valproic Acid—epilepsy syndrome	8.76e-05	0.000462	CcSEcCtD
Topotecan—Leukopenia—Pregabalin—epilepsy syndrome	8.74e-05	0.000461	CcSEcCtD
Topotecan—Rash—Fosphenytoin—epilepsy syndrome	8.71e-05	0.00046	CcSEcCtD
Topotecan—Dermatitis—Fosphenytoin—epilepsy syndrome	8.7e-05	0.000459	CcSEcCtD
Topotecan—Haemoglobin—Topiramate—epilepsy syndrome	8.7e-05	0.000459	CcSEcCtD
Topotecan—Asthenia—Clonazepam—epilepsy syndrome	8.69e-05	0.000458	CcSEcCtD
Topotecan—Rhinitis—Topiramate—epilepsy syndrome	8.68e-05	0.000458	CcSEcCtD
Topotecan—Back pain—Gabapentin—epilepsy syndrome	8.66e-05	0.000457	CcSEcCtD
Topotecan—Headache—Fosphenytoin—epilepsy syndrome	8.66e-05	0.000457	CcSEcCtD
Topotecan—Haemorrhage—Topiramate—epilepsy syndrome	8.65e-05	0.000457	CcSEcCtD
Topotecan—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.65e-05	0.000456	CcSEcCtD
Topotecan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	8.63e-05	0.000455	CcSEcCtD
Topotecan—Asthenia—Phenytoin—epilepsy syndrome	8.63e-05	0.000455	CcSEcCtD
Topotecan—Nausea—Midazolam—epilepsy syndrome	8.61e-05	0.000454	CcSEcCtD
Topotecan—Hypoaesthesia—Topiramate—epilepsy syndrome	8.61e-05	0.000454	CcSEcCtD
Topotecan—Muscle spasms—Gabapentin—epilepsy syndrome	8.61e-05	0.000454	CcSEcCtD
Topotecan—Diarrhoea—Zonisamide—epilepsy syndrome	8.6e-05	0.000454	CcSEcCtD
Topotecan—Pharyngitis—Topiramate—epilepsy syndrome	8.59e-05	0.000453	CcSEcCtD
Topotecan—Asthenia—Oxcarbazepine—epilepsy syndrome	8.58e-05	0.000453	CcSEcCtD
Topotecan—Pruritus—Clonazepam—epilepsy syndrome	8.57e-05	0.000452	CcSEcCtD
Topotecan—Vomiting—Vigabatrin—epilepsy syndrome	8.56e-05	0.000452	CcSEcCtD
Topotecan—Skin disorder—Valproic Acid—epilepsy syndrome	8.56e-05	0.000452	CcSEcCtD
Topotecan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	8.52e-05	0.00045	CcSEcCtD
Topotecan—Cough—Pregabalin—epilepsy syndrome	8.52e-05	0.00045	CcSEcCtD
Topotecan—Pruritus—Phenytoin—epilepsy syndrome	8.51e-05	0.000449	CcSEcCtD
Topotecan—Nausea—Levetiracetam—epilepsy syndrome	8.5e-05	0.000449	CcSEcCtD
Topotecan—Rash—Vigabatrin—epilepsy syndrome	8.49e-05	0.000448	CcSEcCtD
Topotecan—Dizziness—Felbamate—epilepsy syndrome	8.49e-05	0.000448	CcSEcCtD
Topotecan—Dermatitis—Vigabatrin—epilepsy syndrome	8.48e-05	0.000448	CcSEcCtD
Topotecan—Pruritus—Oxcarbazepine—epilepsy syndrome	8.46e-05	0.000447	CcSEcCtD
Topotecan—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.46e-05	0.000446	CcSEcCtD
Topotecan—Headache—Vigabatrin—epilepsy syndrome	8.44e-05	0.000445	CcSEcCtD
Topotecan—Vomiting—Diazepam—epilepsy syndrome	8.43e-05	0.000445	CcSEcCtD
Topotecan—Anorexia—Valproic Acid—epilepsy syndrome	8.4e-05	0.000443	CcSEcCtD
Topotecan—ABCB1—brain—epilepsy syndrome	8.4e-05	0.00631	CbGeAlD
Topotecan—Rash—Diazepam—epilepsy syndrome	8.36e-05	0.000441	CcSEcCtD
Topotecan—Dermatitis—Diazepam—epilepsy syndrome	8.35e-05	0.000441	CcSEcCtD
Topotecan—Myalgia—Pregabalin—epilepsy syndrome	8.31e-05	0.000439	CcSEcCtD
Topotecan—Arthralgia—Pregabalin—epilepsy syndrome	8.31e-05	0.000439	CcSEcCtD
Topotecan—Chest pain—Pregabalin—epilepsy syndrome	8.31e-05	0.000439	CcSEcCtD
Topotecan—Ill-defined disorder—Gabapentin—epilepsy syndrome	8.31e-05	0.000438	CcSEcCtD
Topotecan—Dizziness—Zonisamide—epilepsy syndrome	8.31e-05	0.000438	CcSEcCtD
Topotecan—Headache—Diazepam—epilepsy syndrome	8.31e-05	0.000438	CcSEcCtD
Topotecan—Diarrhoea—Clonazepam—epilepsy syndrome	8.28e-05	0.000437	CcSEcCtD
Topotecan—Anaemia—Gabapentin—epilepsy syndrome	8.28e-05	0.000437	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.26e-05	0.000436	CcSEcCtD
Topotecan—Asthenia—Carbamazepine—epilepsy syndrome	8.24e-05	0.000435	CcSEcCtD
Topotecan—Diarrhoea—Phenytoin—epilepsy syndrome	8.23e-05	0.000434	CcSEcCtD
Topotecan—Discomfort—Pregabalin—epilepsy syndrome	8.21e-05	0.000433	CcSEcCtD
Topotecan—Nausea—Fosphenytoin—epilepsy syndrome	8.21e-05	0.000433	CcSEcCtD
Topotecan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.19e-05	0.000432	CcSEcCtD
Topotecan—Angioedema—Gabapentin—epilepsy syndrome	8.18e-05	0.000432	CcSEcCtD
Topotecan—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.17e-05	0.000431	CcSEcCtD
Topotecan—Vomiting—Felbamate—epilepsy syndrome	8.16e-05	0.000431	CcSEcCtD
Topotecan—Pruritus—Carbamazepine—epilepsy syndrome	8.12e-05	0.000429	CcSEcCtD
Topotecan—Rash—Felbamate—epilepsy syndrome	8.09e-05	0.000427	CcSEcCtD
Topotecan—Dermatitis—Felbamate—epilepsy syndrome	8.08e-05	0.000427	CcSEcCtD
Topotecan—Malaise—Gabapentin—epilepsy syndrome	8.08e-05	0.000426	CcSEcCtD
Topotecan—Headache—Felbamate—epilepsy syndrome	8.04e-05	0.000424	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.03e-05	0.000424	CcSEcCtD
Topotecan—Leukopenia—Gabapentin—epilepsy syndrome	8.02e-05	0.000423	CcSEcCtD
Topotecan—Dizziness—Clonazepam—epilepsy syndrome	8.01e-05	0.000422	CcSEcCtD
Topotecan—Nausea—Vigabatrin—epilepsy syndrome	8e-05	0.000422	CcSEcCtD
Topotecan—Vomiting—Zonisamide—epilepsy syndrome	7.99e-05	0.000421	CcSEcCtD
Topotecan—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.97e-05	0.000421	CcSEcCtD
Topotecan—Asthenia—Lamotrigine—epilepsy syndrome	7.96e-05	0.00042	CcSEcCtD
Topotecan—Dizziness—Phenytoin—epilepsy syndrome	7.95e-05	0.00042	CcSEcCtD
Topotecan—Rash—Zonisamide—epilepsy syndrome	7.92e-05	0.000418	CcSEcCtD
Topotecan—Infection—Pregabalin—epilepsy syndrome	7.92e-05	0.000418	CcSEcCtD
Topotecan—Paraesthesia—Valproic Acid—epilepsy syndrome	7.92e-05	0.000418	CcSEcCtD
Topotecan—Dermatitis—Zonisamide—epilepsy syndrome	7.91e-05	0.000418	CcSEcCtD
Topotecan—Dizziness—Oxcarbazepine—epilepsy syndrome	7.91e-05	0.000417	CcSEcCtD
Topotecan—Nausea—Diazepam—epilepsy syndrome	7.88e-05	0.000416	CcSEcCtD
Topotecan—Headache—Zonisamide—epilepsy syndrome	7.87e-05	0.000415	CcSEcCtD
Topotecan—Dyspnoea—Valproic Acid—epilepsy syndrome	7.86e-05	0.000415	CcSEcCtD
Topotecan—Diarrhoea—Carbamazepine—epilepsy syndrome	7.85e-05	0.000414	CcSEcCtD
Topotecan—Angiopathy—Topiramate—epilepsy syndrome	7.85e-05	0.000414	CcSEcCtD
Topotecan—Pruritus—Lamotrigine—epilepsy syndrome	7.85e-05	0.000414	CcSEcCtD
Topotecan—Immune system disorder—Topiramate—epilepsy syndrome	7.82e-05	0.000412	CcSEcCtD
Topotecan—Nervous system disorder—Pregabalin—epilepsy syndrome	7.82e-05	0.000412	CcSEcCtD
Topotecan—Cough—Gabapentin—epilepsy syndrome	7.81e-05	0.000412	CcSEcCtD
Topotecan—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.8e-05	0.000412	CcSEcCtD
Topotecan—Mediastinal disorder—Topiramate—epilepsy syndrome	7.8e-05	0.000412	CcSEcCtD
Topotecan—Chills—Topiramate—epilepsy syndrome	7.77e-05	0.00041	CcSEcCtD
Topotecan—Dyspepsia—Valproic Acid—epilepsy syndrome	7.76e-05	0.000409	CcSEcCtD
Topotecan—Skin disorder—Pregabalin—epilepsy syndrome	7.74e-05	0.000408	CcSEcCtD
Topotecan—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.71e-05	0.000407	CcSEcCtD
Topotecan—Vomiting—Clonazepam—epilepsy syndrome	7.7e-05	0.000406	CcSEcCtD
Topotecan—Decreased appetite—Valproic Acid—epilepsy syndrome	7.66e-05	0.000404	CcSEcCtD
Topotecan—Alopecia—Topiramate—epilepsy syndrome	7.65e-05	0.000404	CcSEcCtD
Topotecan—Vomiting—Phenytoin—epilepsy syndrome	7.65e-05	0.000403	CcSEcCtD
Topotecan—Rash—Clonazepam—epilepsy syndrome	7.63e-05	0.000403	CcSEcCtD
Topotecan—Dermatitis—Clonazepam—epilepsy syndrome	7.63e-05	0.000402	CcSEcCtD
Topotecan—Myalgia—Gabapentin—epilepsy syndrome	7.62e-05	0.000402	CcSEcCtD
Topotecan—Chest pain—Gabapentin—epilepsy syndrome	7.62e-05	0.000402	CcSEcCtD
Topotecan—Arthralgia—Gabapentin—epilepsy syndrome	7.62e-05	0.000402	CcSEcCtD
Topotecan—Nausea—Felbamate—epilepsy syndrome	7.62e-05	0.000402	CcSEcCtD
Topotecan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.61e-05	0.000402	CcSEcCtD
Topotecan—Vomiting—Oxcarbazepine—epilepsy syndrome	7.61e-05	0.000401	CcSEcCtD
Topotecan—Fatigue—Valproic Acid—epilepsy syndrome	7.6e-05	0.000401	CcSEcCtD
Topotecan—Anorexia—Pregabalin—epilepsy syndrome	7.6e-05	0.000401	CcSEcCtD
Topotecan—Dizziness—Carbamazepine—epilepsy syndrome	7.59e-05	0.000401	CcSEcCtD
Topotecan—Diarrhoea—Lamotrigine—epilepsy syndrome	7.59e-05	0.000401	CcSEcCtD
Topotecan—Headache—Clonazepam—epilepsy syndrome	7.58e-05	0.0004	CcSEcCtD
Topotecan—Rash—Phenytoin—epilepsy syndrome	7.58e-05	0.0004	CcSEcCtD
Topotecan—Dermatitis—Phenytoin—epilepsy syndrome	7.58e-05	0.0004	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.57e-05	0.0004	CcSEcCtD
Topotecan—Rash—Oxcarbazepine—epilepsy syndrome	7.54e-05	0.000398	CcSEcCtD
Topotecan—Constipation—Valproic Acid—epilepsy syndrome	7.54e-05	0.000398	CcSEcCtD
Topotecan—Pain—Valproic Acid—epilepsy syndrome	7.54e-05	0.000398	CcSEcCtD
Topotecan—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.54e-05	0.000398	CcSEcCtD
Topotecan—Headache—Phenytoin—epilepsy syndrome	7.53e-05	0.000398	CcSEcCtD
Topotecan—Malnutrition—Topiramate—epilepsy syndrome	7.53e-05	0.000398	CcSEcCtD
Topotecan—Discomfort—Gabapentin—epilepsy syndrome	7.53e-05	0.000397	CcSEcCtD
Topotecan—Headache—Oxcarbazepine—epilepsy syndrome	7.49e-05	0.000395	CcSEcCtD
Topotecan—Nausea—Zonisamide—epilepsy syndrome	7.46e-05	0.000394	CcSEcCtD
Topotecan—Dizziness—Lamotrigine—epilepsy syndrome	7.34e-05	0.000387	CcSEcCtD
Topotecan—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.31e-05	0.000386	CcSEcCtD
Topotecan—Vomiting—Carbamazepine—epilepsy syndrome	7.3e-05	0.000385	CcSEcCtD
Topotecan—Back pain—Topiramate—epilepsy syndrome	7.29e-05	0.000385	CcSEcCtD
Topotecan—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.27e-05	0.000383	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.26e-05	0.000383	CcSEcCtD
Topotecan—Infection—Gabapentin—epilepsy syndrome	7.26e-05	0.000383	CcSEcCtD
Topotecan—Muscle spasms—Topiramate—epilepsy syndrome	7.24e-05	0.000382	CcSEcCtD
Topotecan—Rash—Carbamazepine—epilepsy syndrome	7.24e-05	0.000382	CcSEcCtD
Topotecan—Dermatitis—Carbamazepine—epilepsy syndrome	7.23e-05	0.000382	CcSEcCtD
Topotecan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.21e-05	0.00038	CcSEcCtD
Topotecan—Nausea—Clonazepam—epilepsy syndrome	7.19e-05	0.000379	CcSEcCtD
Topotecan—Headache—Carbamazepine—epilepsy syndrome	7.19e-05	0.000379	CcSEcCtD
Topotecan—Nervous system disorder—Gabapentin—epilepsy syndrome	7.17e-05	0.000378	CcSEcCtD
Topotecan—Paraesthesia—Pregabalin—epilepsy syndrome	7.16e-05	0.000378	CcSEcCtD
Topotecan—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.16e-05	0.000378	CcSEcCtD
Topotecan—Nausea—Phenytoin—epilepsy syndrome	7.14e-05	0.000377	CcSEcCtD
Topotecan—Dyspnoea—Pregabalin—epilepsy syndrome	7.11e-05	0.000375	CcSEcCtD
Topotecan—Nausea—Oxcarbazepine—epilepsy syndrome	7.11e-05	0.000375	CcSEcCtD
Topotecan—Skin disorder—Gabapentin—epilepsy syndrome	7.1e-05	0.000375	CcSEcCtD
Topotecan—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.07e-05	0.000373	CcSEcCtD
Topotecan—Vomiting—Lamotrigine—epilepsy syndrome	7.05e-05	0.000372	CcSEcCtD
Topotecan—Urticaria—Valproic Acid—epilepsy syndrome	7e-05	0.00037	CcSEcCtD
Topotecan—Rash—Lamotrigine—epilepsy syndrome	7e-05	0.000369	CcSEcCtD
Topotecan—Ill-defined disorder—Topiramate—epilepsy syndrome	6.99e-05	0.000369	CcSEcCtD
Topotecan—Dermatitis—Lamotrigine—epilepsy syndrome	6.99e-05	0.000369	CcSEcCtD
Topotecan—Abdominal pain—Valproic Acid—epilepsy syndrome	6.97e-05	0.000368	CcSEcCtD
Topotecan—Body temperature increased—Valproic Acid—epilepsy syndrome	6.97e-05	0.000368	CcSEcCtD
Topotecan—Anorexia—Gabapentin—epilepsy syndrome	6.97e-05	0.000368	CcSEcCtD
Topotecan—Anaemia—Topiramate—epilepsy syndrome	6.96e-05	0.000367	CcSEcCtD
Topotecan—Headache—Lamotrigine—epilepsy syndrome	6.95e-05	0.000367	CcSEcCtD
Topotecan—Decreased appetite—Pregabalin—epilepsy syndrome	6.93e-05	0.000366	CcSEcCtD
Topotecan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.88e-05	0.000363	CcSEcCtD
Topotecan—Fatigue—Pregabalin—epilepsy syndrome	6.87e-05	0.000363	CcSEcCtD
Topotecan—Nausea—Carbamazepine—epilepsy syndrome	6.82e-05	0.00036	CcSEcCtD
Topotecan—Pain—Pregabalin—epilepsy syndrome	6.82e-05	0.00036	CcSEcCtD
Topotecan—Constipation—Pregabalin—epilepsy syndrome	6.82e-05	0.00036	CcSEcCtD
Topotecan—Malaise—Topiramate—epilepsy syndrome	6.79e-05	0.000358	CcSEcCtD
Topotecan—Leukopenia—Topiramate—epilepsy syndrome	6.74e-05	0.000356	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.66e-05	0.000351	CcSEcCtD
Topotecan—Nausea—Lamotrigine—epilepsy syndrome	6.59e-05	0.000348	CcSEcCtD
Topotecan—Cough—Topiramate—epilepsy syndrome	6.57e-05	0.000347	CcSEcCtD
Topotecan—Feeling abnormal—Pregabalin—epilepsy syndrome	6.57e-05	0.000347	CcSEcCtD
Topotecan—Paraesthesia—Gabapentin—epilepsy syndrome	6.56e-05	0.000346	CcSEcCtD
Topotecan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.52e-05	0.000344	CcSEcCtD
Topotecan—Dyspnoea—Gabapentin—epilepsy syndrome	6.52e-05	0.000344	CcSEcCtD
Topotecan—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.5e-05	0.000343	CcSEcCtD
Topotecan—Dyspepsia—Gabapentin—epilepsy syndrome	6.43e-05	0.000339	CcSEcCtD
Topotecan—Chest pain—Topiramate—epilepsy syndrome	6.41e-05	0.000338	CcSEcCtD
Topotecan—Arthralgia—Topiramate—epilepsy syndrome	6.41e-05	0.000338	CcSEcCtD
Topotecan—Myalgia—Topiramate—epilepsy syndrome	6.41e-05	0.000338	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.37e-05	0.000336	CcSEcCtD
Topotecan—Decreased appetite—Gabapentin—epilepsy syndrome	6.35e-05	0.000335	CcSEcCtD
Topotecan—Discomfort—Topiramate—epilepsy syndrome	6.34e-05	0.000334	CcSEcCtD
Topotecan—Urticaria—Pregabalin—epilepsy syndrome	6.33e-05	0.000334	CcSEcCtD
Topotecan—Asthenia—Valproic Acid—epilepsy syndrome	6.33e-05	0.000334	CcSEcCtD
Topotecan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.31e-05	0.000333	CcSEcCtD
Topotecan—Fatigue—Gabapentin—epilepsy syndrome	6.3e-05	0.000332	CcSEcCtD
Topotecan—Abdominal pain—Pregabalin—epilepsy syndrome	6.3e-05	0.000332	CcSEcCtD
Topotecan—Body temperature increased—Pregabalin—epilepsy syndrome	6.3e-05	0.000332	CcSEcCtD
Topotecan—Pain—Gabapentin—epilepsy syndrome	6.25e-05	0.00033	CcSEcCtD
Topotecan—Constipation—Gabapentin—epilepsy syndrome	6.25e-05	0.00033	CcSEcCtD
Topotecan—Pruritus—Valproic Acid—epilepsy syndrome	6.24e-05	0.000329	CcSEcCtD
Topotecan—Infection—Topiramate—epilepsy syndrome	6.11e-05	0.000322	CcSEcCtD
Topotecan—Diarrhoea—Valproic Acid—epilepsy syndrome	6.03e-05	0.000318	CcSEcCtD
Topotecan—Nervous system disorder—Topiramate—epilepsy syndrome	6.03e-05	0.000318	CcSEcCtD
Topotecan—Feeling abnormal—Gabapentin—epilepsy syndrome	6.02e-05	0.000318	CcSEcCtD
Topotecan—Thrombocytopenia—Topiramate—epilepsy syndrome	6.02e-05	0.000318	CcSEcCtD
Topotecan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.98e-05	0.000315	CcSEcCtD
Topotecan—Skin disorder—Topiramate—epilepsy syndrome	5.97e-05	0.000315	CcSEcCtD
Topotecan—Hyperhidrosis—Topiramate—epilepsy syndrome	5.94e-05	0.000314	CcSEcCtD
Topotecan—Hypersensitivity—Pregabalin—epilepsy syndrome	5.87e-05	0.00031	CcSEcCtD
Topotecan—Anorexia—Topiramate—epilepsy syndrome	5.86e-05	0.000309	CcSEcCtD
Topotecan—Dizziness—Valproic Acid—epilepsy syndrome	5.83e-05	0.000308	CcSEcCtD
Topotecan—Urticaria—Gabapentin—epilepsy syndrome	5.81e-05	0.000306	CcSEcCtD
Topotecan—Body temperature increased—Gabapentin—epilepsy syndrome	5.78e-05	0.000305	CcSEcCtD
Topotecan—Abdominal pain—Gabapentin—epilepsy syndrome	5.78e-05	0.000305	CcSEcCtD
Topotecan—Asthenia—Pregabalin—epilepsy syndrome	5.72e-05	0.000302	CcSEcCtD
Topotecan—Pruritus—Pregabalin—epilepsy syndrome	5.64e-05	0.000298	CcSEcCtD
Topotecan—Vomiting—Valproic Acid—epilepsy syndrome	5.61e-05	0.000296	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.6e-05	0.000296	CcSEcCtD
Topotecan—Rash—Valproic Acid—epilepsy syndrome	5.56e-05	0.000293	CcSEcCtD
Topotecan—Dermatitis—Valproic Acid—epilepsy syndrome	5.55e-05	0.000293	CcSEcCtD
Topotecan—Headache—Valproic Acid—epilepsy syndrome	5.52e-05	0.000291	CcSEcCtD
Topotecan—Paraesthesia—Topiramate—epilepsy syndrome	5.52e-05	0.000291	CcSEcCtD
Topotecan—Dyspnoea—Topiramate—epilepsy syndrome	5.48e-05	0.000289	CcSEcCtD
Topotecan—Diarrhoea—Pregabalin—epilepsy syndrome	5.45e-05	0.000288	CcSEcCtD
Topotecan—Dyspepsia—Topiramate—epilepsy syndrome	5.41e-05	0.000286	CcSEcCtD
Topotecan—Hypersensitivity—Gabapentin—epilepsy syndrome	5.38e-05	0.000284	CcSEcCtD
Topotecan—Decreased appetite—Topiramate—epilepsy syndrome	5.35e-05	0.000282	CcSEcCtD
Topotecan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.31e-05	0.00028	CcSEcCtD
Topotecan—Fatigue—Topiramate—epilepsy syndrome	5.3e-05	0.00028	CcSEcCtD
Topotecan—Dizziness—Pregabalin—epilepsy syndrome	5.27e-05	0.000278	CcSEcCtD
Topotecan—Pain—Topiramate—epilepsy syndrome	5.26e-05	0.000277	CcSEcCtD
Topotecan—Constipation—Topiramate—epilepsy syndrome	5.26e-05	0.000277	CcSEcCtD
Topotecan—Asthenia—Gabapentin—epilepsy syndrome	5.24e-05	0.000277	CcSEcCtD
Topotecan—Nausea—Valproic Acid—epilepsy syndrome	5.24e-05	0.000276	CcSEcCtD
Topotecan—Pruritus—Gabapentin—epilepsy syndrome	5.17e-05	0.000273	CcSEcCtD
Topotecan—Vomiting—Pregabalin—epilepsy syndrome	5.07e-05	0.000267	CcSEcCtD
Topotecan—Feeling abnormal—Topiramate—epilepsy syndrome	5.07e-05	0.000267	CcSEcCtD
Topotecan—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.03e-05	0.000265	CcSEcCtD
Topotecan—Rash—Pregabalin—epilepsy syndrome	5.03e-05	0.000265	CcSEcCtD
Topotecan—Dermatitis—Pregabalin—epilepsy syndrome	5.02e-05	0.000265	CcSEcCtD
Topotecan—Diarrhoea—Gabapentin—epilepsy syndrome	5e-05	0.000264	CcSEcCtD
Topotecan—Headache—Pregabalin—epilepsy syndrome	4.99e-05	0.000263	CcSEcCtD
Topotecan—Urticaria—Topiramate—epilepsy syndrome	4.88e-05	0.000258	CcSEcCtD
Topotecan—Abdominal pain—Topiramate—epilepsy syndrome	4.86e-05	0.000256	CcSEcCtD
Topotecan—Body temperature increased—Topiramate—epilepsy syndrome	4.86e-05	0.000256	CcSEcCtD
Topotecan—Dizziness—Gabapentin—epilepsy syndrome	4.83e-05	0.000255	CcSEcCtD
Topotecan—Nausea—Pregabalin—epilepsy syndrome	4.73e-05	0.00025	CcSEcCtD
Topotecan—Vomiting—Gabapentin—epilepsy syndrome	4.65e-05	0.000245	CcSEcCtD
Topotecan—Rash—Gabapentin—epilepsy syndrome	4.61e-05	0.000243	CcSEcCtD
Topotecan—Dermatitis—Gabapentin—epilepsy syndrome	4.6e-05	0.000243	CcSEcCtD
Topotecan—Headache—Gabapentin—epilepsy syndrome	4.58e-05	0.000242	CcSEcCtD
Topotecan—Hypersensitivity—Topiramate—epilepsy syndrome	4.53e-05	0.000239	CcSEcCtD
Topotecan—Asthenia—Topiramate—epilepsy syndrome	4.41e-05	0.000233	CcSEcCtD
Topotecan—Pruritus—Topiramate—epilepsy syndrome	4.35e-05	0.00023	CcSEcCtD
Topotecan—Nausea—Gabapentin—epilepsy syndrome	4.34e-05	0.000229	CcSEcCtD
Topotecan—Diarrhoea—Topiramate—epilepsy syndrome	4.21e-05	0.000222	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.17e-05	0.00101	CbGpPWpGaD
Topotecan—Dizziness—Topiramate—epilepsy syndrome	4.07e-05	0.000215	CcSEcCtD
Topotecan—ABCG2—Metabolism—L2HGDH—epilepsy syndrome	4e-05	0.000966	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PDXK—epilepsy syndrome	4e-05	0.000966	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADK—epilepsy syndrome	4e-05	0.000966	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FAR1—epilepsy syndrome	4e-05	0.000966	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GLUD1—epilepsy syndrome	4e-05	0.000966	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CERS1—epilepsy syndrome	4e-05	0.000966	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.98e-05	0.000961	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—FOS—epilepsy syndrome	3.95e-05	0.000954	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.92e-05	0.000947	CbGpPWpGaD
Topotecan—Vomiting—Topiramate—epilepsy syndrome	3.91e-05	0.000206	CcSEcCtD
Topotecan—Rash—Topiramate—epilepsy syndrome	3.88e-05	0.000205	CcSEcCtD
Topotecan—Dermatitis—Topiramate—epilepsy syndrome	3.87e-05	0.000204	CcSEcCtD
Topotecan—Headache—Topiramate—epilepsy syndrome	3.85e-05	0.000203	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.81e-05	0.000921	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	3.69e-05	0.000891	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.67e-05	0.000887	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—EPM2A—epilepsy syndrome	3.66e-05	0.000883	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PNPO—epilepsy syndrome	3.66e-05	0.000883	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NHLRC1—epilepsy syndrome	3.66e-05	0.000883	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GAMT—epilepsy syndrome	3.66e-05	0.000883	CbGpPWpGaD
Topotecan—Nausea—Topiramate—epilepsy syndrome	3.65e-05	0.000193	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.55e-05	0.000856	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.55e-05	0.000856	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	3.5e-05	0.000845	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	3.5e-05	0.000845	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	3.5e-05	0.000845	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—QDPR—epilepsy syndrome	3.4e-05	0.000821	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA4—epilepsy syndrome	3.4e-05	0.000821	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.4e-05	0.000821	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	3.34e-05	0.000807	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	3.34e-05	0.000806	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	3.34e-05	0.000806	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—COX3—epilepsy syndrome	3.2e-05	0.000772	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.16e-05	0.000763	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	3.09e-05	0.000746	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PFKL—epilepsy syndrome	3.03e-05	0.000732	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—KCNB1—epilepsy syndrome	3.03e-05	0.000732	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLCO1A2—epilepsy syndrome	3.03e-05	0.000732	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CACNA2D2—epilepsy syndrome	3.03e-05	0.000732	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC6A8—epilepsy syndrome	3.03e-05	0.000732	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	2.92e-05	0.000706	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA13—epilepsy syndrome	2.85e-05	0.000689	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	2.84e-05	0.000685	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.82e-05	0.00068	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—UPB1—epilepsy syndrome	2.77e-05	0.000669	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NEU1—epilepsy syndrome	2.77e-05	0.000669	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ATIC—epilepsy syndrome	2.77e-05	0.000669	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.72e-05	0.000657	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HSD17B4—epilepsy syndrome	2.67e-05	0.000644	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.65e-05	0.00064	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.65e-05	0.00064	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.62e-05	0.000633	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GBE1—epilepsy syndrome	2.58e-05	0.000622	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPP1R3C—epilepsy syndrome	2.58e-05	0.000622	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.57e-05	0.000621	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.55e-05	0.000617	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	2.53e-05	0.000612	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.53e-05	0.000612	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.53e-05	0.000611	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	2.53e-05	0.000611	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.52e-05	0.000608	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	2.5e-05	0.000603	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.49e-05	0.000601	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	2.48e-05	0.000598	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.43e-05	0.000586	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.43e-05	0.000586	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.43e-05	0.000586	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.43e-05	0.000586	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ASAH1—epilepsy syndrome	2.42e-05	0.000585	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.4e-05	0.000578	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—STXBP1—epilepsy syndrome	2.36e-05	0.000569	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.31e-05	0.000557	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NT5E—epilepsy syndrome	2.3e-05	0.000555	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALAD—epilepsy syndrome	2.3e-05	0.000555	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.29e-05	0.000552	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.27e-05	0.000549	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.25e-05	0.000544	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CACNA1A—epilepsy syndrome	2.19e-05	0.000529	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDH7A1—epilepsy syndrome	2.19e-05	0.000529	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.16e-05	0.000522	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADK—epilepsy syndrome	2.16e-05	0.000522	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.16e-05	0.000522	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.16e-05	0.000522	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.16e-05	0.000522	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.16e-05	0.000522	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.15e-05	0.000519	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.15e-05	0.000518	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ST3GAL3—epilepsy syndrome	2.14e-05	0.000518	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.13e-05	0.000513	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.12e-05	0.000512	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADSL—epilepsy syndrome	2.1e-05	0.000507	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.06e-05	0.000498	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GLUL—epilepsy syndrome	2.06e-05	0.000497	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CACNA1D—epilepsy syndrome	2.02e-05	0.000488	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.99e-05	0.000479	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.98e-05	0.000478	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.98e-05	0.000478	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.98e-05	0.000478	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.98e-05	0.000478	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.92e-05	0.000463	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.92e-05	0.000463	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TXNRD1—epilepsy syndrome	1.89e-05	0.000457	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.89e-05	0.000456	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.88e-05	0.000454	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.86e-05	0.00045	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.84e-05	0.000444	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.84e-05	0.000444	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA4—epilepsy syndrome	1.84e-05	0.000444	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.84e-05	0.000444	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AQP1—epilepsy syndrome	1.84e-05	0.000443	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.8e-05	0.000436	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.76e-05	0.000424	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—COX3—epilepsy syndrome	1.73e-05	0.000417	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.71e-05	0.000413	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CHRM3—epilepsy syndrome	1.66e-05	0.000401	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	1.66e-05	0.000401	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.65e-05	0.000398	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.64e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.64e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.64e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.64e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.64e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.58e-05	0.000382	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.56e-05	0.000377	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.52e-05	0.000368	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.5e-05	0.000362	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.5e-05	0.000362	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.5e-05	0.000362	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.49e-05	0.00036	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.44e-05	0.000348	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.42e-05	0.000342	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.39e-05	0.000336	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.39e-05	0.000336	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.34e-05	0.000325	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.33e-05	0.000322	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.33e-05	0.000322	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.33e-05	0.000322	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.33e-05	0.000322	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.33e-05	0.000322	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.33e-05	0.000322	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	1.32e-05	0.000319	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	1.31e-05	0.000317	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.31e-05	0.000316	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.3e-05	0.000313	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.27e-05	0.000308	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.25e-05	0.000301	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.24e-05	0.0003	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.24e-05	0.0003	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.24e-05	0.000298	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.22e-05	0.000294	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.21e-05	0.000293	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.18e-05	0.000286	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.18e-05	0.000286	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	1.18e-05	0.000286	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.16e-05	0.00028	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.14e-05	0.000274	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.13e-05	0.000274	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.13e-05	0.000274	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.13e-05	0.000273	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.13e-05	0.000272	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	1.13e-05	0.000272	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BCHE—epilepsy syndrome	1.12e-05	0.000271	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.11e-05	0.000269	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.09e-05	0.000264	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.09e-05	0.000263	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	1.07e-05	0.000258	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.07e-05	0.000257	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.06e-05	0.000256	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLCB1—epilepsy syndrome	1.06e-05	0.000256	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TH—epilepsy syndrome	1.05e-05	0.000255	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.02e-05	0.000247	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.02e-05	0.000245	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.01e-05	0.000244	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.01e-05	0.000243	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AQP1—epilepsy syndrome	9.93e-06	0.00024	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.24e-06	0.000223	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.24e-06	0.000223	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.24e-06	0.000223	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	9.08e-06	0.000219	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	8.98e-06	0.000217	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CHRM3—epilepsy syndrome	8.98e-06	0.000217	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	8.89e-06	0.000215	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMOX1—epilepsy syndrome	8.8e-06	0.000213	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAT—epilepsy syndrome	8.69e-06	0.00021	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	8.59e-06	0.000207	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	8.59e-06	0.000207	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCB1—epilepsy syndrome	8.45e-06	0.000204	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.07e-06	0.000195	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPX1—epilepsy syndrome	7.86e-06	0.00019	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.85e-06	0.00019	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.65e-06	0.000185	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.65e-06	0.000185	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	7.32e-06	0.000177	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.3e-06	0.000176	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.3e-06	0.000176	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.14e-06	0.000172	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	7.13e-06	0.000172	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	7.09e-06	0.000171	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7e-06	0.000169	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AGT—epilepsy syndrome	6.89e-06	0.000166	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.86e-06	0.000166	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.76e-06	0.000163	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOE—epilepsy syndrome	6.75e-06	0.000163	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.74e-06	0.000163	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.4e-06	0.000154	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.3e-06	0.000152	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.12e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.1e-06	0.000147	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	6.09e-06	0.000147	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BCHE—epilepsy syndrome	6.07e-06	0.000146	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—POMC—epilepsy syndrome	5.8e-06	0.00014	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.79e-06	0.00014	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.72e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TH—epilepsy syndrome	5.7e-06	0.000138	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.53e-06	0.000134	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.53e-06	0.000134	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—epilepsy syndrome	5.29e-06	0.000128	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.76e-06	0.000115	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAT—epilepsy syndrome	4.7e-06	0.000113	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—epilepsy syndrome	4.62e-06	0.000112	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.51e-06	0.000109	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.4e-06	0.000106	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.37e-06	0.000105	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.25e-06	0.000103	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.94e-06	9.52e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.75e-06	9.06e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.74e-06	9.02e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AGT—epilepsy syndrome	3.72e-06	8.99e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOE—epilepsy syndrome	3.65e-06	8.81e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.57e-06	8.61e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.53e-06	8.51e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TH—epilepsy syndrome	3.51e-06	8.48e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—POMC—epilepsy syndrome	3.13e-06	7.57e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.93e-06	7.08e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.89e-06	6.99e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—epilepsy syndrome	2.86e-06	6.9e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.81e-06	6.8e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.62e-06	6.32e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.5e-06	6.04e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—epilepsy syndrome	2.32e-06	5.61e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.29e-06	5.54e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.25e-06	5.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.93e-06	4.66e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.76e-06	4.25e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.54e-06	3.72e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.26e-06	3.03e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.74e-07	1.87e-05	CbGpPWpGaD
